Hikma Pharmaceutical | HIK - Ebit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Hikma Pharmaceutical

Hikma Pharmaceutical reported $253M in EBIT for its fiscal semester ending in December of 2022.


Ebit Change
Almirall SA ALM:SM EUR 8.84M 1.47M
Artemis Alpha ATS:LN GBP -16578000 10.12M
AstraZeneca AZN:LN USD 2.78B 943M
Bayer BAYN:GR EUR 3.4B 534M
Fresenius FRE:GR EUR 908M 425M
Galapagos GLPG:NA EUR 21.97M 154.43M
Genmab GEN:DC DKK 437M 2.23B
GlaxoSmithKline GSK:LN GBP 1.92B 483M
Hikma Pharmaceutical HIK:LN USD 253M 3M
Lonza Group LONN:SW CHF 901M 203M
Orion ORNBV:FH EUR 55.5M 14.8M
Recordati REC:IM EUR 175.35M 70.82M
Roche Holding ROG:VX 8.49B 3.05B
UCB UCB:BB 124M 427M